We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Cyberonics Refute Claims of Lax Postmarket Oversight
FDA, Cyberonics Refute Claims of Lax Postmarket Oversight
November 12, 2010
Cyberonics and the FDA are scratching their heads over a recent study that claims the agency provides insufficient oversight to ensure the safety of devices that hit the U.S. market.